Rupatadine: global safety evaluation in allergic rhinitis and urticaria.

Mullol, Joaquim; González-Núñez, Vanesa; Bachert, Claus

doi:10.1080/14740338.2016.1221399

Record: found
Abstract: found
Article: not found

Rupatadine: global safety evaluation in allergic rhinitis and urticaria.

Author(s): Vanesa González-Núñez ¹ , Claus Bachert ² , Joaquim Mullol ³

Publication date (Electronic): Oct 2016

Journal: Expert opinion on drug safety

Publisher: Informa UK Limited

Keywords: H1-antihistamine, H1-receptor antagonist, PAF antagonist, Rupatadine, allergic rhinitis, chronic spontaneous urticaria, intermittent, perennial, persistent, pharmacodynamics, pharmacokinetics, safety, seasonal, second-generation antihistamine, therapeutic use, urticaria

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Rupatadine is a second-generation H1-antihistamine with dual affinity for histamine H1 and PAF receptors. Rupatadine is indicated for the treatment of allergic rhinitis and urticaria.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Expert Opin Drug Saf

Title: Expert opinion on drug safety

Publisher: Informa UK Limited

ISSN (Electronic): 1744-764X

ISSN (Print): 1474-0338

Publication date (Electronic): Oct 2016

Volume: 15

Issue: 10

Affiliations

[1 ] a Department of Allergology , Hospital Quirón , Barcelona , Spain.

[2 ] b Upper Airway Research Laboratory, Department of Oto-rhino-laryngology , Ghent University , Ghent , Belgium.

[3 ] c Unitat de Rinologia & Clínica de l'Olfacte, ENT Department , Hospital Clínic i Universitari; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS); and CIBER de Enfermedades Respiratorias (CIBERES) , Barcelona , Spain.

Article

DOI: 10.1080/14740338.2016.1221399

PubMed ID: 27500993

SO-VID: cb301ca7-3041-4f49-a361-d416d6e9c406

History

Keywords: allergic rhinitis,intermittent,perennial,persistent,pharmacodynamics,pharmacokinetics,safety,seasonal,second-generation antihistamine,therapeutic use,urticaria,H1-antihistamine,H1-receptor antagonist,PAF antagonist,Rupatadine,chronic spontaneous urticaria

Data availability:

Keywords: allergic rhinitis, intermittent, perennial, persistent, pharmacodynamics, pharmacokinetics, safety, seasonal, second-generation antihistamine, therapeutic use, urticaria, H1-antihistamine, H1-receptor antagonist, PAF antagonist, Rupatadine, chronic spontaneous urticaria

Rupatadine: global safety evaluation in allergic rhinitis and urticaria.

Read this article at

Abstract

Related collections

Global Health Next Generation Network

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 82

Cited by 7